
GenMark Diagnostics, Inc. GNMK
GenMark Diagnostics, Inc. DIO Ratio 2011-2026 | GNMK
Annual DIO Ratio GenMark Diagnostics, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| 75.1 | 69.4 | 72.9 | 123 | 123 | 72.8 | 59.4 | 48.3 | 62.5 | 128 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 128 | 48.3 | 83.4 |
DIO Ratio of other stocks in the Medical devices industry
| Issuer | DIO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Aziyo Biologics
AZYO
|
108 | - | 1.37 % | $ 20.5 M | ||
|
Conformis
CFMS
|
160 | - | - | $ 16.4 M | ||
|
Bruker Corporation
BRKR
|
216 | $ 39.27 | -1.36 % | $ 5.85 K | ||
|
Lianluo Smart Limited
LLIT
|
50 | - | 24.59 % | $ 44.8 M | ||
|
Cardiovascular Systems
CSII
|
192 | - | 0.15 % | $ 844 M | ||
|
Cutera
CUTR
|
135 | - | -10.19 % | $ 1.99 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
240 | - | -5.86 % | $ 30.6 M | ||
|
Acutus Medical
AFIB
|
108 | - | -26.83 % | $ 2.62 M | ||
|
Dynatronics Corporation
DYNT
|
91.1 | - | 14.99 % | $ 929 K | ||
|
Eargo
EAR
|
85.3 | - | - | $ 10.2 M | ||
|
Cognyte Software Ltd.
CGNT
|
76.7 | $ 7.82 | - | $ 561 M | ||
|
Allied Healthcare Products
AHPI
|
133 | - | 3.58 % | $ 2.21 M | ||
|
Second Sight Medical Products
EYES
|
175 | - | -0.97 % | $ 54.4 M | ||
|
EDAP TMS S.A.
EDAP
|
163 | $ 3.99 | - | $ 149 M | ||
|
AdaptHealth Corp.
AHCO
|
20.2 | $ 9.4 | - | $ 1.27 B | ||
|
FONAR Corporation
FONR
|
13.9 | $ 18.5 | -0.32 % | $ 121 M | ||
|
Apollo Endosurgery
APEN
|
160 | - | - | $ 475 M | ||
|
CONMED Corporation
CNMD
|
205 | $ 43.41 | - | $ 1.35 B | ||
|
Electromed
ELMD
|
91.2 | $ 23.98 | - | $ 203 M | ||
|
CryoLife, Inc.
CRY
|
312 | - | -4.14 % | $ 702 M | ||
|
Avinger
AVGR
|
332 | - | -20.74 % | $ 369 K | ||
|
CHF Solutions, Inc.
CHFS
|
247 | - | 1.15 % | $ 34.5 M | ||
|
AxoGen
AXGN
|
238 | $ 29.83 | - | $ 1.37 B | ||
|
Apyx Medical Corporation
APYX
|
213 | $ 3.17 | -3.35 % | $ 110 M | ||
|
InMode Ltd.
INMD
|
307 | $ 13.6 | - | $ 879 M | ||
|
Axonics Modulation Technologies
AXNX
|
290 | - | - | $ 3.31 B | ||
|
IRIDEX Corporation
IRIX
|
125 | $ 1.43 | 1.42 % | $ 23.1 M | ||
|
IRadimed Corporation
IRMD
|
251 | $ 104.29 | - | $ 1.32 B | ||
|
Itamar Medical Ltd.
ITMR
|
212 | - | 0.03 % | $ 1.58 B | ||
|
Accuray Incorporated
ARAY
|
164 | $ 0.53 | - | $ 54.5 M | ||
|
Misonix, Inc.
MSON
|
272 | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
10.1 | - | - | $ 111 M | ||
|
Medigus Ltd.
MDGS
|
411 | - | 10.28 % | $ 55.5 M | ||
|
LivaNova PLC
LIVN
|
127 | $ 68.43 | -2.62 % | $ 3.73 B | ||
|
Pulmonx Corporation
LUNG
|
282 | $ 1.53 | - | $ 59.8 M | ||
|
Cytosorbents Corporation
CTSO
|
106 | $ 0.8 | 6.81 % | $ 43.5 M | ||
|
Align Technology
ALGN
|
83.8 | $ 182.64 | - | $ 13.7 B | ||
|
Medtronic PLC
MDT
|
168 | $ 96.71 | - | $ 124 B | ||
|
Intersect ENT, Inc.
XENT
|
145 | - | - | $ 955 M | ||
|
Inari Medical
NARI
|
220 | - | - | $ 4.23 B | ||
|
Butterfly Network
BFLY
|
790 | $ 3.68 | - | $ 779 M | ||
|
BIOLASE
BIOL
|
154 | - | -13.19 % | $ 166 K | ||
|
Abbott Laboratories
ABT
|
120 | $ 113.61 | - | $ 198 B | ||
|
NuVasive
NUVA
|
355 | - | - | $ 2.07 B | ||
|
Nevro Corp.
NVRO
|
291 | - | - | $ 217 M | ||
|
BioSig Technologies
BSGM
|
7.1 K | - | 37.08 % | $ 85.7 M | ||
|
Boston Scientific Corporation
BSX
|
169 | $ 73.85 | - | $ 109 B |